<\/p>\n\n\n\n
\u5b89\u9054\u5bdb\u5b50\u30fb\u67ff\u4e26\u7fa9\u5b8f\u30fb\u90e1\u5c71\u5c1a\u7d00\u30fb\u8d8a\u91ce \u4e00\u535a\u30fb\u7027\u672c(\u732a\u702c)\u5f69\u52a0. (2025). \u5b50\u3092\u5168\u982d\u3067\u5b88\u308b\uff1a\u98fc\u80b2\u4e0b\u30a2\u30b8\u30a2\u30be\u30a6\u306e\u975e\u8840\u7e01\u7fa4\u308c\u306b\u304a\u3051\u308b\u8b66\u6212\u30fb\u96c6\u5408\u8981\u56e0\u306e\u63a2\u7d22\u7684\u691c\u8a0e. \u65e5\u672c\u52d5\u7269\u884c\u52d5\u5b66\u4f1a\u7b2c44\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u8d64\u6c60\u3000\u77ac\u30fb\u5927\u69fb\u7f8e\u4f73\u30fb\u6d66\u8302\u4e45\u30fb\u7dd2\u65b9\u662d\u5f66\u30fb\u798f\u6b66\u654f\u592b\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u7d9a\u767a\u6027\u9032\u884c\u6027\u5931\u8a9e\uff08DPA\uff09\uff1aPSP\/CBS\u306e\u65b0\u305f\u306a\u8a00\u8a9e\u969c\u5bb3\u306e\u81e8\u5e8a\u6982\u5ff5. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a. <\/p>\n\n\n\n
\u5b89\u85e4\u9999\u7e54\u30fb\u5927\u6cbc\u9032. (2025). \u4eba\u3068AI\u306e\u5171\u751f\u306b\u5411\u3051\u3066\uff1a\u4eba\u9593\u2013AI\u76f8\u4e92\u4f5c\u7528\u3092\u63a2\u308b. \u65e5\u672c\u793e\u4f1a\u5fc3\u7406\u5b66\u4f1a\u7b2c66\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u5f35\u96c5\u8343\u30fb\u5c0f\u6797\u6167\u30fb\u6cb3\u897f\u54f2\u5b50. (2025). \u81ea\u9589\u75c7\u50be\u5411\u306f\u8907\u6570\u9854\u306b\u5bfe\u3059\u308b\u77e5\u899a\u51e6\u7406\u6642\u9593\u306b\u95a2\u308f\u308b. \u5317\u6d77\u9053\u5fc3\u7406\u5b66\u4f1a\u7b2c72\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u571f\u4e95\u7fd4\u5e73\u30fb\u5c0f\u91ce\u7d14\u5e73\u30fb\u5c71\u53e3\u667a\u5927\u30fb\u5c0f\u6d5c\u7965\u5b50. (2025). \u5916\u4ea4\u306e\u3069\u3053\u306b\u5973\u6027\u306f\u3044\u308b\u306e\u304b\uff1f\u3000\u5916\u52d9\u7701\u672c\u7701\u5e79\u90e8\u306e\u30b8\u30a7\u30f3\u30c0\u30fc\u30d0\u30e9\u30f3\u30b9\u306e\u5206\u6790. 2025\u5e74\u5ea6\u65e5\u672c\u653f\u6cbb\u5b66\u4f1a\u7814\u7a76\u5927\u4f1a.<\/p>\n\n\n\n
\u6c5f\u53e3\u514b\u7d00\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u4e0a\u5e8a\u5c1a\u30fb\u98ef\u7530\u6709\u7d00\u30fb\u6ff1\u7530\u664b\u8f14\u30fb\u4f0a\u85e4\u82b3\u5b50\u30fb\u672c\u9593\u65e9\u82d7\u30fb\u6b66\u4e95\u9ebb\u5b50\u30fb\u68ee\u82e5\u6587\u96c4\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u6b69\u884c\u52d5\u753b\u3068\u6df1\u5c64\u5b66\u7fd2\u3092\u5229\u7528\u3057\u305f\u810a\u9ac4\u5c0f\u8133\u5909\u6027\u75c7\u60a3\u8005\u306eSARA\u30b9\u30b3\u30a2\u306e\u4e88\u6e2c. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
Fujii, S,. Yaguchi, H., Kudo, A., Eguchi, K., Nomura, T., Uwatoko, H., Shirai, S., Iwata, I., Matsushima, M., Tanaka, K., Yoneda, M., Kimura, A., Hamada, Y., Fukumoto, Y., Yamagishi, Y., Nagai, Y., & Yabe, I. (2025). Establish-ment of assay system KLHL11 antibodies and results in au-toimmune cerebellar ataxia. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
\u85e4\u4e95\u4fe1\u592a\u6717\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u5de5\u85e4\u5f70\u5f66\u30fb\u91ce\u6751\u592a\u4e00\u30fb\u4e0a\u5e8a\u5c1a\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u5f53\u9662\u3067\u81e8\u5e8a\u7684\u306b\u81ea\u5df1\u514d\u75ab\u6027\u5c0f\u8133\u5931\u8abf\u75c7\u3068\u8a3a\u65ad\u3057\u305f\u75c7\u4f8b\u306e\u81ea\u5df1\u6297\u4f53\u6e2c\u5b9a\u3001\u306a\u3089\u3073\u306b\u514d\u75ab\u7d44\u7e54\u5b66\u7684\u691c\u8a0e. \u7b2c37\u56de\u65e5\u672c\u795e\u7d4c\u514d\u75ab\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.<\/p>\n\n\n\n
\u539f\u7530\u76f4\u8f1d\u30fb\u6cb3\u897f\u54f2\u5b50. (2025). \u9854\u8868\u60c5\u306b\u5bfe\u3059\u308b\u6ce8\u610f\u306e\u6642\u9593\u7684\u63a8\u79fb. \u7b2c39\u56de\u65e5\u672c\u751f\u7406\u5fc3\u7406\u5b66\u4f1a\u5927\u4f1a.<\/p>\n\n\n\n
\u9577\u8c37\u5ddd\u7531\u5f25\u30aa\u30ea\u30d0\u30fb\u5bfa\u57a3 \u7a42\u9999\u30fb\u7cf8\u4e95 \u98a8\u97f3\u30fb\u7532\u6590\u7530 \u76f4\u5b50\u30fb\u9ad8\u6a4b \u821e\u30fb\u5927\u6cbc \u9032. (2025). \u74b0\u5883\u914d\u616e\u884c\u52d5\u306b\u95a2\u308f\u308b\u4fa1\u5024\u89b3\u306e\u6f5c\u5728\u69cb\u9020\u306e\u691c\u8a0e\uff1a\u65e5\u672c\u4eba\u30b5\u30f3\u30d7\u30eb\u306b\u304a\u3051\u308b\u56e0\u5b50\u5206\u6790. \u65e5\u672c\u793e\u4f1a\u5fc3\u7406\u5b66\u4f1a\u7b2c66\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u6797\u822a\u5e73\u30fb \u4f0a\u85e4\u6cf0\u5e79\u30fb \u4f0a\u85e4\u5f69\u4e43\u30fb \u77f3\u7530\u9686\u609f\u30fb \u9808\u85e4\u54f2\u5e73. (2025). \u54fa\u4e73\u985e\u5b66\u306b\u6c42\u3081\u3089\u308c\u308b\u300e\u30b5\u30a4\u30a8\u30f3\u30b9\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u300f\u3092\u63a2\u308b . \u65e5\u672c\u54fa\u4e73\u985e\u5b66\u4f1a2025\u5e74\u5ea6\u5927\u4f1a. <\/p>\n\n\n\n
\u5e02\u4e4b\u5ddd\u840c\u5948\u7f8e\u30fb\u677e\u5cf6\u7406\u660e\u30fb\u4f50\u4e45\u5d8b\u7814\u30fb\u91d1\u8c37\u6cf0\u5b8f\u30fb\u897f\u672c\u5c1a\u6a39\u30fb\u6fa4\u7530\u6f64\u30fb\u677e\u5ca1\u5065\u30fb\u4e0a\u6749\u6625\u96c4\u30fb\u5357\u5c1a\u54c9\u30fb\u4f50\u5149\u4e00\u4e5f\u30fb\u6b66\u4e95\u9ebb\u5b50\u30fb\u4e45\u539f\u771f\u30fb\u7389\u8170\u66c9\u5b50\u30fb\u4f50\u85e4\u5178\u5b8f\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u591a\u7cfb\u7d71\u840e\u7e2e\u75c7\u306b\u304a\u3051\u308b\u4fb5\u8972\u7684\u6cbb\u7642\u4ecb\u5165\u306e\u50be\u5411\u3068\u30ea\u30b9\u30af\u56e0\u5b50\u306e\u89e3\u6790. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
\u4e94\u5341\u5d50\u8061\u6c70\u30fb\u65e5\u4e0b\u90e8\u6625\u91ce\u30fb\u7d50\u57ce\u96c5\u6a39. (2025). \u81ea\u5c0a\u5fc3\u306e\u65e5\u7c73\u5dee\u3092\u652f\u3048\u308b\u793e\u4f1a\u7684\u76f8\u4e92\u4f5c\u7528\u30e1\u30ab\u30cb\u30ba\u30e0 \u95a2\u4fc2\u6d41\u52d5\u6027\u3068\u79f0\u8cdb\u30fb\u6279\u5224\u306e\u5a92\u4ecb\u52b9\u679c\u306e\u691c\u8a0e. \u65e5\u672c\u793e\u4f1a\u5fc3\u7406\u5b66\u4f1a\u7b2c66\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u77f3\u5ddd\u6953\u30fb\u5bae\u5cb8\u9ebb\u8863\u30fb\u8107\u7530\u96c5\u5927\u30fb\u6d66\u8302\u4e45\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u8840\u6f3f\u4ea4\u63db\u304c\u6709\u7528\u3060\u3063\u305f\u81ea\u5df1\u514d\u75ab\u6027glial fi-brillary acidic protein (GFAP) \u30a2\u30b9\u30c8\u30ed\u30b5\u30a4\u30c8\u30d1\u30c1\u30fc\u306e1\u4f8b. \u7b2c43\u56de\u65e5\u672c\u795e\u7d4c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.<\/p>\n\n\n\n
\u4f0a\u85e4\u6cf0\u5e79. (2025). \u5e02\u2ea0\u306b\u3088\u308b\u30d2\u30b0\u30de\u306e\u51fa\u6ca1\u6291\u5236\u5bfe\u7b56\u3092\u9806\u5fdc\u7684\u306b\u9032\u3081\u308b\u306b\u306f?\u2015\u653e\u68c4\u679c\u6a39\u4f10\u63a1\u30dc\u30e9\u30f3\u30c6\u30a3\u30a2\u306b\u304a\u3051\u308b\u53c2\u52a0\u52d5\u6a5f\u306b\u7740\u76ee\u3057\u3066 . \u7b2c30 \u56de\u300c\u91ce\u751f\u751f\u7269\u3068\u793e\u4f1a\u300d\u5b66\u4f1a\u5927\u4f1a.<\/p>\n\n\n\n
\u5ca9\u7530\u80b2\u5b50\u30fb\u677e\u5cf6\u7406\u660e\u30fb\u4e2d\u6751\u60a0\u4e00\u30fb\u5c3e\u5d0e\u5b5d\u723e\u30fb\u718a\u8c37\u8061\u7f8e\u30fb\u52a0\u85e4\u9686\u5f18\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u8efd\u5ea6\u8a8d\u77e5\u969c\u5bb3\u60a3\u8005\u306b\u304a\u3051\u308b\u63e1\u529b\u304c\u8a8d\u77e5\u6a5f\u80fd\u3078\u53ca\u307c\u3059\u5f71\u97ff. \u7b2c44\u56de\u65e5\u672c\u8a8d\u77e5\u75c7\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.<\/p>\n\n\n\n
\u5ca9\u7530\u80b2\u5b50\u30fb\u677e\u5cf6\u7406\u660e\u30fb\u4e2d\u6751\u60a0\u4e00\u30fb\u5c3e\u5d0e\u5b5d\u723e\u30fb\u718a\u8c37\u8061\u7f8e\u30fb\u52a0\u85e4\u9686\u5f18\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u8efd\u5ea6\u8a8d\u77e5\u969c\u5bb3\u60a3\u8005\u306b\u304a\u3051\u308b\u63e1\u529b\u304c\u8a8d\u77e5\u6a5f\u80fd\u3078\u53ca\u307c\u3059\u5f71\u97ff. \u7b2c44\u56de\u65e5\u672c\u8a8d\u77e5\u75c7\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.<\/p>\n\n\n\n
\u67ff\u4e26\u7fa9\u5b8f\u30fb\u5b89\u9054\u5bdb\u5b50\u30fb\u90e1\u5c71\u5c1a\u7d00\u30fb\u7027\u672c(\u732a\u702c)\u5f69\u52a0\u30fb\u8d8a\u91ce \u4e00\u535a. (2025). \u30a2\u30b8\u30a2\u30be\u30a6\u304c\u8b66\u6212\u96c6\u5408\u6642\u306b\u767a\u3059\u308b\u8d85\u4f4e\u5468\u6ce2\u97f3\u306e\u7279\u5fb4. \u65e5\u672c\u52d5\u7269\u884c\u52d5\u5b66\u4f1a\u7b2c44\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u5c0f\u6797\u6167\u30fb\u6cb3\u897f\u54f2\u5b50. (2025). \u559c\u3073\u8868\u60c5\u9854\u306e\u9078\u629e\u7684\u8a08\u6570\u306b\u304a\u3051\u308b\u5171\u611f\u7684\u95a2\u5fc3\u306e\u5f71\u97ff. \u65e5\u672c\u5fc3\u7406\u5b66\u4f1a\u7b2c89\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u5c0f\u6797\u6167\u30fb\u6cb3\u897f\u54f2\u5b50. (2025). \u8907\u6570\u4ed6\u8005\u306e\u559c\u3073\u8868\u60c5\u306e\u8a08\u6570\u306b\u3068\u3082\u306a\u3046ERP\u6210\u5206. \u7b2c43\u56de\u751f\u7406\u5fc3\u7406\u5b66\u4f1a\u5927\u4f1a.<\/p>\n\n\n\n
\u5c0f\u6797\u667a\u4e4b\u30fb\u9ad8\u7530\u30e2\u30e2\u30fb\u767d\u4e95\u6d69\u4ecb\u30fb\u67f4\u7530\u4f91\u79c0\u30fb\u5927\u6cbc\u9032\u30fb\u4fdd\u9ad8\u5fb9\u751f\u30fb\u6751\u4e0a\u9053\u592b. (2025). \u5fa9\u8208\u518d\u751f\u5229\u7528\u306e\u898f\u6a21\u3068\u770c\u5916\u6700\u7d42\u51e6\u5206\u306e\u793e\u4f1a\u53d7\u5bb9\uff0e\u7b2c38\u56de\u65e5\u672c\u30ea\u30b9\u30af\u5b66\u4f1a\u5e74\u6b21\u5927\u4f1a\u4f01\u753b\u30bb\u30c3\u30b7\u30e7\u30f3\u300c\u9664\u53bb\u571f\u58cc\u7b49\u306e\u798f\u5cf6\u770c\u5916\u6700\u7d42\u51e6\u5206\u3068\u5fa9\u8208\u518d\u751f\u5229\u7528. \u7b2c38\u56de\u65e5\u672c\u30ea\u30b9\u30af\u5b66\u4f1a\u5e74\u6b21\u5927\u4f1a\u4f01\u753b\u30bb\u30c3\u30b7\u30e7\u30f3\u300c\u9664\u53bb\u571f\u58cc\u7b49\u306e\u798f\u5cf6\u770c\u5916\u6700\u7d42\u51e6\u5206\u3068\u5fa9\u8208\u518d\u751f\u5229\u7528\uff1a\u793e\u4f1a\u53d7\u5bb9\u6027\u8a55\u4fa1\u3068\u5b9f\u73fe\u3078\u306e\u8ab2\u984c\u300d.<\/p>\n\n\n\n
\u53e4\u8cc0\u9054\u4e5f\u30fb \u9ad9\u7551\u512a\u30fb \u4f0a\u85e4\u6cf0\u5e79. (2025). \u91ce\u751f\u52d5\u7269\u7ba1\u7406\u306b\u304a\u3051\u308b\u793e\u4f1a\u79d1\u5b66\u306e\u4e8b\u4f8b\u7814\u7a76:\u5230\u9054\u70b9\u3068\u4eca\u5f8c\u306e\u5c55\u671b(\u9752\u5e74\u90e8\u4f1aTS). \u7b2c30 \u56de\u300c\u91ce\u751f\u751f\u7269\u3068\u793e\u4f1a\u300d\u5b66\u4f1a\u5927\u4f1a.<\/p>\n\n\n\n
Kudo, A., Yaguchi, H., Watanabe, M., Nomura, T., Tanaka, K., Takahashi, H., Hatakeyama, S., & Yabe, I. (2025). Shotgun proteomics analysis of immunoprecipitation in five cases with LGI1 antibody encephalitis. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
\u65e5\u4e0b\u90e8\u6625\u91ce\u30fb\u8cb4\u5802\u96c4\u592a\u30fb\u7d50\u57ce\u96c5\u6a39. (2025). \u95a2\u4fc2\u6d41\u52d5\u6027\u3068\u8a55\u5224\u60c5\u5831\u6d41\u901a\u306e\u6587\u5316\u5dee:\u30aa\u30f3\u30e9\u30a4\u30f3\u30ec\u30d3\u30e5\u30fc\u3092\u7528\u3044\u305f\u5927\u898f\u6a21\u56fd\u969b\u6bd4\u8f03. \u65e5\u672c\u4eba\u9593\u884c\u52d5\u9032\u5316\u5b66\u4f1a\u7b2c18\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u65e5\u4e0b\u90e8\u6625\u91ce\u30fb\u7d50\u57ce\u96c5\u6a39. (2025). \u7570\u306a\u308b\u95a2\u4fc2\u6d41\u52d5\u6027\u4e0b\u306b\u304a\u3051\u308b\u8a55\u5224\u7ba1\u7406\u6226\u7565. \u65e5\u672c\u793e\u4f1a\u5fc3\u7406\u5b66\u4f1a\u7b2c66\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u5de5\u85e4\u5f70\u5f66\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u5c0f\u8133\u6027\u904b\u52d5\u5931\u8abf\u75c7\u3068\u60aa\u6027\u816b\u760d. \u7b2c37\u56de\u65e5\u672c\u795e\u7d4c\u514d\u75ab\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \u30b7\u30f3\u30dd\u30b8\u30a6\u30e09.<\/p>\n\n\n\n
Matsushima, M., Sakushima, K., Kanatani, Y., Nishimoto, N., Sawada, J., Matsuoka, T., Uesugi, H., Minami, N., Sako, K., Takei, A., Hisahara, S., Tamakoshi, A., Sato, N., & Yabe, I. (2025). Natural history and epidemiological study of multiple system atrophy in Hokkaido: HoRC-MSA 2014-2024. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
Miyatake, S., Doi, H., Yaguchi, H., Morino, H., Izumi, Y., Shimohata, T., Yoshida, K., Adachi, H., Tanaka, F., Yabe, I., & Matsumoto, N. (2025). Unraveling the Genetic Land-scape of SCA27B: Nanopore Sequencing of GAA-FGF14 Ataxia in Japanese. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
\u5bae\u5185\u6cf0\u4ecb\u30fb \u5927\u77f3\u667a\u7f8e. (2025). \u91ce\u751f\u52d5\u7269\u3068\u4eba\u306e\u3042\u3064\u308c\u304d\u306e\u8cea\u7684\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u306e\u5fc5\u8981\u6027\u3068\u305d\u306e\u65b9\u6cd5\uff1a\u5317\u6d77\u9053\u306e\u30d2\u30b0\u30de\u3092\u4e8b\u4f8b\u306b. \u7b2c30 \u56de\u300c\u91ce\u751f\u751f\u7269\u3068\u793e\u4f1a\u300d\u5b66\u4f1a\u5927\u4f1a.<\/p>\n\n\n\n
\u6c34\u5730\u667a\u57fa\u30fb\u76f8\u6d25\u7422\u78e8\u30fb\u6afb\u4e95\u967d\u4e00\u30fb\u68ee\u4e0b\u667a\u4e4b\u30fb\u5409\u6751\u5065\u4f51\u30fb\u9234\u9e7f\u7adc\u53f8\u30fb\u77e2\u90e8\u4e00\u90ce\u30fb\u5ca9\u7530\u80b2\u5b50\u30fb\u52dd\u91ce\u96c5\u592e\u30fb\u6df1\u898b\u7950\u6a39\u30fb\u5c0f\u6c60\u6625\u6a39\u30fb\u4e95\u51fa\u4fca\u5b8f\u30fb\u4e09\u6fa4\u5712\u5b50\u30fb\u6851\u539f\u8061. (2025). \u672b\u68a2\u795e\u7d4c\u75be\u60a3\u306e\u8a3a\u65ad\u652f\u63f4AI\u30e2\u30c7\u30eb\u306e\u958b\u767a\uff1a\u591a\u65bd\u8a2d\u5171\u540c\u7814\u7a76. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
Mizushima, K., Shirai, S., Iwata, I., Matsushima, M., Yaguchi, H., & Yabe, I. (2025). Autosomal dominant spinocerebellar degeneration (AD-SCD) genetic testing compared after in-surance. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
\u4e2d\u6751\u4eae\u4e00\u30fb\u85e4\u5185\u7384\u898f\u30fb\u71b1\u7530\u76f4\u6a39\u30fb\u677e\u7530\u4f91\u7f8e\u30fb\u68ee\u672c\u609f\u30fb\u4f0a\u85e4\u5927\u8f14\u30fb\u52dd\u91ce\u96c5\u592e\u30fb\u548c\u6cc9\u552f\u4fe1\u30fb\u68ee\u7530\u5149\u54c9\u30fb\u5ca9\u7530\u80b2\u5b50\u30fb\u77e2\u90e8\u4e00\u90ce\u30fb\u670d\u90e8\u4fe1\u5b5d\u30fb\u5e73\u5c71\u525b\u4e45\u30fb\u72e9\u91ce\u4fee\u30fb\u9234\u6728\u76f4\u8f1d\u30fb\u9752\u6728\u6b63\u5fd7\u30fb\u9053\u52c7\u5b66\u30fb\u5ca1\u91ce\u6804\u4e4b\u30fb\u4e2d\u6764\u660c\u5f18\u30fb\u7956\u7236\u6c5f\u5143\u30fbJaCALS. (2025). \u7b4b\u840e\u7e2e\u6027\u5074\u7d22\u786c\u5316\u75c7\u60a3\u8005\u306e\u767a\u75c7\u5e74\u9f62\u306b\u95a2\u9023\u3059\u308b\u65b0\u898f\u907a\u4f1d\u7684\u56e0\u5b50\u306e\u540c\u5b9a. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
\u4e2d\u6751\u4fca\u592a\u90ce\u30fb\u5c71\u7530\u4e00\u8cb4\u30fb\u5800\u5185\u4e00\u5b8f\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u598a\u5a20\u4e2d\u306b\u767a\u75c7\u3057\u518d\u767a\u3092\u7e70\u308a\u8fd4\u3057\u305f\u7dd1\u81bf\u83cc\u6027\u9ac4\u819c\u708e. \u7b2c29\u56de\u65e5\u672c\u795e\u7d4c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
\u91ce\u6751\u592a\u4e00\u30fb\u677e\u5cf6\u7406\u660e\u30fb\u6b66\u77f3\u4f91\u675c\u30fb\u77f3\u5742\u5091\u30fb\u85e4\u7530\u7a42\u6ce2\u30fb\u5411\u4e2d\u91ce\u5b9f\u592e\u30fb\u67f4\u7530\u6709\u82b1\u30fb\u897f\u91ce\u4e00\u4e09\u30fb\u5c71\u7530\u5d07\u5f18\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u5fc3\u75be\u60a3\u767a\u898b\u3092\u5951\u6a5f\u306b\u8a3a\u65ad\u518d\u8003\u3068\u306a\u308a\u3001\u672c\u4eba\u3068\u5bb6\u65cf\u3078\u306e\u5bfe\u5fdc\u304c\u53ef\u80fd\u306b\u306a\u3063\u305fEmery-Dreifuss\u578b\u7b4b\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u306e1\u4f8b. \u7b2c49\u56de\u65e5\u672c\u907a\u4f1d\u30ab\u30a6\u30f3\u30bb\u30ea\u30f3\u30b0\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.<\/p>\n\n\n\n
Nomura, T., Yaguchi, H., Uwatoko, H., Muramatsu, K., Izumi, K., Ujiie, H., Kawashima, A., Fukazawa, T., & Yabe, I. (2025). Three cases of multiple sclerosis presenting with palmoplantar pustulosis while receiving ofatumumab. \u7b2c66\u56de\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
\u91ce\u6751\u592a\u4e00\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u7530\u4e2d\u5927\u8cb4\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u8131\u9ac4\u306b\u3088\u308b\u8ef8\u7d22\u5909\u6027\u3068\u518d\u9ac4\u9798\u5316\u306bBassoon\uff08BSN\uff09\u30bf\u30f3\u30d1\u30af\u8cea\u5909\u7570\u304c\u4e0e\u3048\u308b\u5f71\u97ff\u306e\u691c\u8a0e. \u7b2c37\u56de\u65e5\u672c\u795e\u7d4c\u514d\u75ab\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000\u7b2c32\u56de\uff08\u4ee4\u548c6\u5e74\u5ea6\uff09\u65e5\u672c\u591a\u767a\u6027\u786c\u5316\u75c7\u5354\u4f1a\u7814\u7a76\u52a9\u6210\u91d1\u53d7\u8cde\u8005\u8b1b\u6f14.<\/p>\n\n\n\n
\u5c0f\u5ddd\u548c\u8a18\u30fb\u91ce\u672c\u6a39\u91cc\u30fb\u52dd\u5143\u6566\u5b50\u30fb\u6797\u5e7c\u5049\u30fb\u85e4\u4e95\u4fe1\u592a\u6717\u30fb\u5de5\u85e4\u5f70\u5f66\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u77e2\u90e8\u4e00\u90ce\u30fb\u9ad9\u6a4b\u7950\u4e8c. (2025). \u4e9c\u6025\u6027\u306b\u9032\u884c\u3059\u308b\u904b\u52d5\u5931\u8abf\u53ca\u3073\u8a8d\u77e5\u6a5f\u80fd\u4f4e\u4e0b\u3001\u30d1\u30fc\u30ad\u30f3\u30bd\u30cb\u30ba\u30e0\u3092\u5448\u3057\u305fSea6l2\u6297\u4f53\u967d\u6027\u8133\u708e\u306e1\u4f8b. \u7b2c37\u56de\u65e5\u672c\u795e\u7d4c\u514d\u75ab\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.<\/p>\n\n\n\n
\u5c0f\u91ce\u3055\u304f\u3089\u30fb\u5ddd\u53e3\u821e\u30fb\u6c34\u9ce5\u7fd4\u4f0d\u30fb\u9ad8\u6a4b\u4f38\u5e78. (2025). \u9593\u63a5\u4e92\u6075\u6027\u306b\u304a\u3051\u308b\u60c5\u5831\u4f1d\u9054\u306e\u6b63\u78ba\u6027\u306e\u691c\u8a0e\uff0d\u8a71\u3057\u5408\u3044\u306b\u4f34\u3046\u540c\u8abf\u306b\u6ce8\u76ee\u3057\u3066\uff0d. \u65e5\u672c\u793e\u4f1a\u5fc3\u7406\u5b66\u4f1a\u7b2c66\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u5c0f\u91ce\u3055\u304f\u3089\u30fb\u9ad8\u6a4b\u4f38\u5e78. (2025). \u96c6\u6a29\u7f70\u5236\u5ea6\u306e\u81ea\u751f\u30e1\u30ab\u30cb\u30ba\u30e0\u306e\u5b9f\u9a13\u7684\u691c\u8a0e. \u6570\u7406\u793e\u4f1a\u5b66\u4f1a\u7b2c79\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u5927\u6728\u8061\u609f\u30fb\u5c71\u53e3\u79c0\u30fb\u4f0a\u5e2b\u96ea\u53cb\u30fb\u5de5\u85e4\u5f70\u5f66\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u7a2e\u4e95\u5584\u4e00\u30fb\u5ca1\u7530\u5b8f\u7f8e\u30fb\u9ad8\u6851\u6075\u7f8e\u30fb\u77e2\u90e8\u4e00\u90ce\u30fb\u7530\u4e2d\u4f38\u54c9\u30fb\u85e4\u6751\u5e79. (2025). \u8853\u524d\u753b\u50cf\u3067\u5185\u5074\u5074\u982d\u8449\u795e\u7d4c\u81a0\u816b\u3092\u7591\u3063\u305f\u6297LGI1\u6297\u4f53\u95a2\u9023\u8133\u708e\u306e2\u4f8b. \u7b2c30\u56de\u65e5\u672c\u8133\u816b\u760d\u306e\u5916\u79d1\u5b66\u4f1a.<\/p>\n\n\n\n
\u592a\u7530\u7dd1\u30fb\u6751\u4e2d\u5fb9\u4eba\u30fb\u6a2a\u6fa4\u6075\u30fb\u570b\u679d\u4fdd\u5e78\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u8133\u795e\u7d4c\u5185\u79d1\u5c02\u9580\u533b\u4e0d\u5728\u5730\u57df\u3067\u306e\u60a3\u8005\u652f\u63f4\u4f53\u5236\u306b\u304a\u3051\u308b\u591a\u8077\u7a2e\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u306e\u8a66\u307f. \u96e3\u75c5\u652f\u63f4\u5b66\u8853\u30b3\u30f3\u30bd\u30fc\u30b7\u30a2\u30e0(\u7b2c13\u56de\u65e5\u672c\u96e3\u75c5\u533b\u7642\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \/ \u7b2c30\u56de\u65e5\u672c\u96e3\u75c5\u770b\u8b77\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \/ \u7b2c11\u56de\u795e\u7d4c\u96e3\u75c5\u30ea\u30cf\u30d3\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u7814\u7a76\u4f1a).<\/p>\n\n\n\n
\u5c3e\u5d0e\u4e00\u90ce (2025). \u6cd5\u3092\u3081\u3050\u308b\u30df\u30b9\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3 \u2014\u73fe\u4ee3\u793e\u4f1a\u306e\u69cb\u9020\u7684\u75c5\u7406\u3068\u6cd5\u306e\u5f79\u5272\u3092\u3081\u3050\u3063\u3066\u2014. \u6771\u65b9\u660e\u73e0\u5927\u8b1b\u6f14\uff08\u83ef\u6771\u653f\u6cd5\u5927\u5b66\uff09.<\/p>\n\n\n\n
\u5c3e\u5d0e\u4e00\u90ce (2025). \u6cd5\u79e9\u5e8f\u306e\u5909\u9077\u3068\u6a21\u5408\u6163\u7fd2. 2025\u5e74\u5ea6\u65e5\u672c\u6cd5\u793e\u4f1a\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
Pan, J., Kudo, A., Yaguchi, H., Fujii, S., Tarisawa, M., Nomura, T., Uwatoko, H., Shirai, S., Iwata, I., Matsushima, M.,\u3000& Yabe, I. (2025). Investigation of anti-KLHL11 antibodies in patients with MSA-C. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
\u6797\u5cf0\u7af9\u30fb\u5c0f\u6797\u6167\u30fb\u6cb3\u897f\u54f2\u5b50. (2025). \u8907\u6570\u4ed6\u8005\u8868\u60c5\u306e\u65e9\u671f\u77e5\u899a\u6bb5\u968e\u306b\u304a\u3051\u308bADHD\u50be\u5411\u306e\u5f71\u97ff. \u65e5\u672c\u5fc3\u7406\u5b66\u4f1a\u7b2c89\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u9f4b\u85e4\u60a0\u8f14\u30fb\u7af9\u6fa4\u6b63\u54f2. (2025). \u9ad8\u4fe1\u983c\u8005\u306f\u306a\u305c\u4ed6\u8005\u306e\u4fe1\u983c\u60c5\u5831\u306b\u654f\u611f\u306a\u306e\u304b\uff1a\u30d9\u30a4\u30b8\u30a2\u30f3\u30fb\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u3088\u308b\u8aac\u660e. \u65e5\u672c\u4eba\u9593\u884c\u52d5\u9032\u5316\u5b66\u4f1a\u7b2c18\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u9f4b\u85e4\u60a0\u8f14\u30fb\u7af9\u6fa4\u6b63\u54f2. (2025). \u4e00\u822c\u7684\u4fe1\u983c\u306e\u793e\u4f1a\u5dee\u306f\u3044\u304b\u306a\u308b\u30e1\u30ab\u30cb\u30ba\u30e0\u304b\u3089\u751f\u3058\u308b\u304b\uff1a\u968e\u5c64\u30d9\u30a4\u30ba\u8a8d\u77e5\u30e2\u30c7\u30eb\u306b\u3088\u308b\u691c\u8a0e. \u65e5\u672c\u793e\u4f1a\u5fc3\u7406\u5b66\u4f1a\u7b2c66\u56de\u5927\u4f1a. <\/p>\n\n\n\n
\u767d\u4e95\u614e\u4e00\u30fb\u5de5\u85e4\u5f70\u5f66\u30fb\u91ce\u6751\u592a\u4e00\u30fb\u4e0a\u5e8a\u3000\u5c1a\u30fb\u5ca9\u7530\u80b2\u5b50\u30fb\u677e\u5cf6\u7406\u660e\u30fb\u4f50\u4e45\u5d8b\u3000\u7814\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u810a\u9ac4\u5c0f\u8133\u5931\u8abf\u75c71\u578b\u306e\u81ea\u7136\u6b74\u8abf\u67fb\u7814\u7a76\uff08\u7b2c2\u7248\uff09. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.<\/p>\n\n\n\n
Song, X., Sugimoto, Y., Takimoto-Inose, A., Tsukahara, Y., Anderson, J.R., & Kuroshima, H. (2025). \u30d5\u30b5\u30aa\u30de\u30ad\u30b6\u30eb\u306b\u304a\u3051\u308b\u7b2c\u4e09\u8005\u793e\u4f1a\u7684\u8a55\u4fa1\u306e\u5f62\u6210\u3068\u66f4\u65b0. \u65e5\u672c\u52d5\u7269\u5fc3\u7406\u5b66\u4f1a\u7b2c85\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u76f8\u99ac\u3086\u3081\u30fbQuentin Ehkirch\u30fb\u4e0a\u539f\u793c\u592e\u5948\u30fb\u4e0a\u6751\u771f\u83dc\u30fb\u8fd1\u7530\u88d5\u4eae\u30fb\u5927\u6cbc\u9032. (2025). \u516c\u6b63\u306a\u914d\u5206\u306f\u826f\u8cea\u306a\u8a0e\u8b70\u3092\u3082\u305f\u3089\u3059\uff1a\u9664\u53bb\u571f\u58cc\u30b2\u30fc\u30e0\u3092\u7528\u3044\u305f\u5efa\u8a2d\u7684\u516c\u8ad6\u5f62\u6210\u306e\u30d7\u30ed\u30bb\u30b9. \u65e5\u672c\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\uff06\u30b2\u30fc\u30df\u30f3\u30b0\u5b66\u4f1a2025\u5e74\u79cb\u671f\u5168\u56fd\u5927\u4f1a.<\/p>\n\n\n\n
\u76f8\u99ac\u3086\u3081\u30fbQuentin Ehkirch\u30fb\u4e0a\u539f\u793c\u592e\u5948\u30fb\u4e2d\u6fa4\u9ad8\u5e2b\u30fb\u8fb0\u5df3\u667a\u884c\u30fb\u6709\u99ac\u6dd1\u5b50\u30fb\u5927\u6cbc\u9032. (2025). \u9664\u53bb\u571f\u58cc\u770c\u5916\u6700\u7d42\u51e6\u5206\u306b\u304a\u3051\u308b\u5019\u88dc\u5730\u6570\u304c\u8b70\u8ad6\u306e\u5e30\u7d50\u306b\u53ca\u307c\u3059\u52b9\u679c \uff1a\u4eee\u60f3\u30b7\u30ca\u30ea\u30aa\u3092\u7528\u3044\u305f\u96c6\u56e3\u8a0e\u8b70\u5b9f\u9a13\u306b\u3088\u308b\u691c\u8a0e. \u7b2c38\u56de\u65e5\u672c\u30ea\u30b9\u30af\u5b66\u4f1a\u5e74\u6b21\u5927\u4f1a\u4f01\u753b\u30bb\u30c3\u30b7\u30e7\u30f3\u300c\u9664\u53bb\u571f\u58cc\u7b49\u306e\u798f\u5cf6\u770c\u5916\u6700\u7d42\u51e6\u5206\u3068\u5fa9\u8208\u518d\u751f\u5229\u7528\uff1a\u793e\u4f1a\u53d7\u5bb9\u6027\u8a55\u4fa1\u3068\u5b9f\u73fe\u3078\u306e\u8ab2\u984c\u300d.<\/p>\n\n\n\n
\u76f8\u99ac\u3086\u3081\u30fbQuentin Ehkirch\u30fb\u4e0a\u539f\u793c\u592e\u5948\u30fb\u4e2d\u6fa4\u9ad8\u5e2b\u30fb\u8fb0\u5df3\u667a\u884c\u30fb\u6709\u99ac\u6dd1\u5b50\u30fb\u5927\u6cbc\u9032. (2025). \u306a\u305c\u9664\u53bb\u571f\u58cc\u306f\u53d7\u3051\u5165\u308c\u3089\u308c\u308b\u306e\u304b \uff1a\u4eee\u60f3\u30b7\u30ca\u30ea\u30aa\u3092\u7528\u3044\u305f\u96c6\u56e3\u8a0e\u8b70\u5b9f\u9a13\u304b\u3089\u5f97\u3089\u308c\u305f\u30c7\u30fc\u30bf\u306b\u5bfe\u3059\u308b\u5b9a\u6027\u7684\u5206\u6790. \u7b2c38\u56de\u65e5\u672c\u30ea\u30b9\u30af\u5b66\u4f1a\u5e74\u6b21\u5927\u4f1a.<\/p>\n\n\n\n
\u76f8\u99ac \u3086\u3081\u30fb\u67f4\u7530 \u4f91\u79c0\u30fb\u5d14 \u9752\u6797\u30fb\u4e2d\u6fa4 \u9ad8\u5e2b\u30fb\u8fb0\u5df3 \u667a\u884c\u30fb\u6709\u99ac \u6dd1\u5b50\u30fb\u5927\u6cbc \u9032. (2025). \u8ca0\u62c5\u914d\u5206\u306e\u516c\u5e73\u3055\u304c\u5f53\u4e8b\u8005\u6027\u306e\u9ad8\u3044\u4eba\u3005\u306e\u8b70\u8ad6\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306e\u691c\u8a0e\uff1a\u9664\u53bb\u571f\u58cc\u798f\u5cf6\u770c\u5916\u51e6\u7406\u554f\u984c\u3092\u984c\u6750\u3068\u3057\u305f\u96c6\u56e3\u8a0e\u8b70\u5b9f\u9a13. \u65e5\u672c\u793e\u4f1a\u5fc3\u7406\u5b66\u4f1a\u7b2c66\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u6731\u4e00\u9cf4\u30fb\u7d50\u57ce\u96c5\u6a39. (2025). The Manipulation of Relational Mobility. \u65e5\u672c\u793e\u4f1a\u5fc3\u7406\u5b66\u4f1a\u7b2c66\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u9ad8\u7530\u30e2\u30e2\u30fb\u6751\u4e0a\u9053\u592b\u30fb\u5927\u6cbc\u9032\u30fb\u4fdd\u9ad8\u5fb9\u751f. (2025). \u713c\u5374\u6b8b\u3055\u306e\u6e1b\u5bb9\u5316\u30b7\u30ca\u30ea\u30aa\u306b\u5bfe\u3059\u308b\u5e02\u6c11\u3068\u5c02\u9580\u5bb6\u306e\u9078\u597d\u306e\u9055\u3044\u3068\u7ba1\u7406\u671f\u9593\u60c5\u5831\u304c\u5e02\u6c11\u306e\u9078\u597d\u306b\u53ca\u307c\u3059\u5f71\u97ff. \u7b2c38\u56de\u65e5\u672c\u30ea\u30b9\u30af\u5b66\u4f1a\u5e74\u6b21\u5927\u4f1a. <\/p>\n\n\n\n
Takahashi-Iwata, I., Tarisawa, M., Uwatoko, H., Matsushima, M., Shirai, S., Yaguchi, H., Ozaki, T., Udo, N., Ikebe, Y., Hirata, K., Kudo, K., & Yabe, I. (2025). Analysis of pa-tients with mild cognitive impairment who are negative for amyloid pathology. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a. <\/p>\n\n\n\n
\u7af9\u897f\u6d77\u4eba\u30fb\u7af9\u6fa4\u6b63\u54f2. (2025). \u96c6\u5408\u77e5\u306b\u304a\u3051\u308b\u5168\u54e1\u4e00\u81f4\u898f\u5247\u306e\u9811\u5065\u6027:\u78ba\u7387\u7684\u306b\u610f\u898b\u8868\u660e\u3059\u308b\u8a71\u3057\u5408\u3044\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u30fb\u30e2\u30c7\u30eb\u306b\u3088\u308b\u691c\u8a0e. \u65e5\u672c\u4eba\u9593\u884c\u52d5\u9032\u5316\u5b66\u4f1a\u7b2c18\u56de\u5927\u4f1a. <\/p>\n\n\n\n
\u7af9\u897f\u6d77\u4eba\u30fb\u7af9\u6fa4\u6b63\u54f2. (2025). \u5168\u54e1\u4e00\u81f4\u898f\u5247\u3068\u78ba\u4fe1\u5ea6\u304c\u751f\u307f\u51fa\u3059\u8a71\u3057\u5408\u3044\u306e\u96c6\u5408\u77e5. \u65e5\u672c\u793e\u4f1a\u5fc3\u7406\u5b66\u4f1a\u7b2c66\u56de\u5927\u4f1a. <\/p>\n\n\n\n
\u7af9\u6fa4\u6b63\u54f2. (2025). \u68ee\u4e2d(2024)\u306b\u5bfe\u3059\u308b\u8ad6\u8a55 \u300e\u4eba\u306e\u5fc3\u306f\u79d1\u5b66\u7684\u4e8b\u5b9f\u306b\u3088\u3063\u3066\u52d5\u304b\u305b\u308b\u306e\u304b\uff1f\u300f. \u65e5\u672c\u751f\u7269\u5730\u7406\u5b66\u4f1a\u5e02\u6c11\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u6b21\u4e16\u4ee3\u306b\u3069\u306e\u3088\u3046\u306a\u793e\u4f1a\u3092\u8d08\u308b\u306e\u304b\uff1f\u300d. <\/p>\n\n\n\n
\u7027\u53e3\u7531\u5b87\u30fb\u7af9\u6fa4\u6b63\u54f2. (2025). \u8cea\u7684\u5fdc\u7b54\u5747\u8861\u3068\u5e73\u5747\u5834. \u65e5\u672c\u7269\u7406\u5b66\u4f1a \u7b2c80\u56de\u5e74\u6b21\u5927\u4f1a. <\/p>\n\n\n\n
\u7027\u672c(\u732a\u702c)\u5f69\u52a0. (2025). \u30a6\u30de\u306e\u751f\u614b\u3068\u3053\u3053\u308d\u2015\u4eba\u99ac\u306e\u671b\u307e\u3057\u3044\u95a2\u4fc2\u6027\u69cb\u7bc9\u306b\u5411\u3051\u3066\u2015. \u65e5\u672c\u52d5\u7269\u884c\u52d5\u5b66\u4f1a\u7b2c44\u56de\u5927\u4f1a.<\/p>\n\n\n\n
\u7027\u672c\u5f69\u52a0\u30fb\u85e4\u7530\u548c\u751f. (2025). \u5354\u529b\u306f\u3001\u30d5\u30b5\u30aa\u30de\u30ad\u30b6\u30eb\u306e\u30b3\u30b9\u30c8\u3092\u4f34\u3046\u5411\u793e\u4f1a\u7684\u306a\u5831\u916c\u5206\u914d\u3092\u4fc3\u9032\u3059\u308b\u304b\uff1f. \u95a2\u897f\u5fc3\u7406\u5b66\u4f1a\u7b2c123\u56de\u5927\u4f1a. <\/p>\n\n\n\n
Tanaka, D., Yaguchi, H., Kudo, A., Yoshizaki, K., Nomura, T., Pan, J., Takahashi, H., Miki, Y., Mori, F., Wakabayashi, K., & Yabe, I. (2025). Analyses of Bassoon knock-in mice until twelve months of age: the second report. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a. <\/p>\n\n\n\n
Tanaka, \uff2d. (2025). Internal model of the cerebellum for rhythm perception(\u62db\u5f85\u8b1b\u6f14). \u7b2c130\u56de\u65e5\u672c\u89e3\u5256\u5b66\u4f1a\u30fb\u7b2c102\u56de\u751f\u7406\u5b66\u4f1a\u30fb\u7b2c98\u56de\u85ac\u7406\u5b66\u4f1a\u5408\u540c\u5927\u4f1a (APPW2025).<\/p>\n\n\n\n
\u7530\u4e2d\u771f\u6a39. (2025). \u5468\u671f\u523a\u6fc0\u306e\u5c0f\u8133\u5185\u90e8\u30e2\u30c7\u30eb(\u62db\u5f85\u8b1b\u6f14). \u7b2c15\u56de\u65e5\u672c\u5c0f\u8133\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a. <\/p>\n\n\n\n
\u6d66\u8302\u4e45\u30fb\u5bae\u5cb8\u9ebb\u8863\u30fb\u77f3\u5ddd\u6953\u30fb\u8107\u7530\u96c5\u5927\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u591a\u767a\u6027\u5358\u795e\u7d4c\u708e\u3092\u5448\u3057\u305f\u597d\u9178\u7403\u6027\u591a\u767a\u8840\u7ba1\u708e\u6027\u8089\u82bd\u816b\u75c7\uff08EGPA\uff09\u306e\u81e8\u5e8a\u50cf\u3068\u6cbb\u7642\u6cd5. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a. <\/p>\n\n\n\n
\u6d66\u8302\u4e45\u30fb\u96dc\u8cc0\u5c07\u30fb\u4e95\u4e0a\u8cb4\u53f8\u30fb\u8107\u7530\u96c5\u5927\u30fb\u5ca9\u7530\u80b2\u5b50\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u5317\u6d77\u9053\u6771\u5317\u5730\u57df\u306e\u6297\u30a2\u30df\u30ed\u30a4\u30c9\u03b2\u6297\u4f53\u85ac\u306e\u4f7f\u7528\u72b6\u6cc1\u3068\u554f\u984c\u70b9. \u96e3\u75c5\u652f\u63f4\u5b66\u8853\u30b3\u30f3\u30bd\u30fc\u30b7\u30a2\u30e0(\u7b2c13\u56de\u65e5\u672c\u96e3\u75c5\u533b\u7642\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \/ \u7b2c30\u56de\u65e5\u672c\u96e3\u75c5\u770b\u8b77\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \/ \u7b2c11\u56de\u795e\u7d4c\u96e3\u75c5\u30ea\u30cf\u30d3\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u7814\u7a76\u4f1a).<\/p>\n\n\n\n
\u6d66\u8302\u4e45\u30fb\u8107\u7530\u96c5\u5927\u30fb\u4e95\u4e0a\u8cb4\u53f8\u30fb\u96dc\u8cc0\u5c07\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u591a\u767a\u6027\u5358\u795e\u7d4c\u708e\u3092\u5448\u3057\u305f\u597d\u9178\u7403\u6027\u591a\u767a\u8840\u7ba1\u708e\u6027\u8089\u82bd\u816b\u75c7\uff08EGPA\uff09\u306e\u81e8\u5e8a\u50cf\u3068\u6cbb\u7642\u6cd5. \u7b2c37\u56de\u65e5\u672c\u795e\u7d4c\u514d\u75ab\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. <\/p>\n\n\n\n
\u4e0a\u5e8a\u5c1a\u30fb\u8db3\u6fa4\u840c\u5948\u7f8e\u30fb\u91ce\u6751\u592a\u4e00\u30fb\u85e4\u4e95\u4fe1\u592a\u6717\u30fb\u7530\u4e2d\u5927\u8cb4\u30fb\u5de5\u85e4\u5f70\u5f66\u30fb\u767d\u4e95\u614e\u4e00\u30fb\u5ca9\u7530\u80b2\u5b50\u30fb\u677e\u5cf6\u7406\u660e\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u5357\u5834\u7814\u4e00\u30fb\u77f3\u7530\u664b\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). Vogt-\u5c0f\u67f3-\u539f\u7530\u75c5\u306b\u304a\u3051\u308b\u8133\u810a\u9ac4\u6db2\u6240\u898b\u306e\u691c\u8a0e. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a. <\/p>\n\n\n\n
\u4e0a\u5e8a\u5c1a\u30fb\u5bae\ufa11\u96c4\u751f\u30fb\u91ce\u6751\u592a\u4e00\u30fb\u5de5\u85e4\u5f70\u5f66\u30fb\u767d\u4e95\u614e\u4e00\u30fb\u5ca9\u7530\u80b2\u5b50\u30fb\u677e\u5cf6\u7406\u660e\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u6d25\u5742\u548c\u6587\u30fb\u4fdd\u524d\u82f1\u5e0c\u30fb\u6d66\u8302\u4e45\u30fb\u677e\u5ca1\u5065\u30fb\u6ff1\u7530\u664b\u8f14\u30fb\u5bae\u5cb8\u9686\u53f8\u30fb\u6df1\u6fa4\u4fca\u884c\u30fb\u5800\u5185\u4e00\u5b8f\u30fb\u65b0\u91ce\u6b63\u660e\u30fb\u83ca\u5730\u8aa0\u5fd7\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u795e\u7d4c\u75be\u60a3\u306b\u5bfe\u3059\u308bDoctor to Patients with Doctor\u5f62\u5f0f\u306e\u30aa\u30f3\u30e9\u30a4\u30f3\u8a3a\u7642\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u96e3\u75c5\u652f\u63f4\u5b66\u8853\u30b3\u30f3\u30bd\u30fc\u30b7\u30a2\u30e0(\u7b2c13\u56de\u65e5\u672c\u96e3\u75c5\u533b\u7642\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \/ \u7b2c30\u56de\u65e5\u672c\u96e3\u75c5\u770b\u8b77\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \/ \u7b2c11\u56de\u795e\u7d4c\u96e3\u75c5\u30ea\u30cf\u30d3\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u7814\u7a76\u4f1a).<\/p>\n\n\n\n
\u4e0a\u5e8a\u5c1a\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u6df1\u6fa4\u4fca\u884c\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u6162\u6027\u9032\u884c\u6027\u306e\u75c5\u5909\u3092\u5448\u3057\u305fAQP4\u6297\u4f53\u967d\u6027\u8996\u795e\u7d4c\u810a\u9ac4\u708e\u30b9\u30da\u30af\u30c8\u30e9\u30e0\u969c\u5bb3\uff08NMOSD\uff09\u306e2\u4f8b. \u7b2c37\u56de\u65e5\u672c\u795e\u7d4c\u514d\u75ab\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. <\/p>\n\n\n\n
\u8107\u7530\u96c5\u5927\u30fb\u96dc\u8cc0\u5c07\u30fb\u4e95\u4e0a\u8cb4\u53f8\u30fb\u6d66\u8302\u4e45\u30fb\u77e2\u53e3\u88d5\u7ae0\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). Gemella morbillorum\u306b\u3088\u308bLemierre\u75c7\u5019\u7fa4\u306b\u4f75\u767a\u3057\u305f\u591a\u767a\u8133\u81bf\u760d\u306e1\u4f8b. \u7b2c29\u56de\u65e5\u672c\u795e\u7d4c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a. <\/p>\n\n\n\n
\u77e2\u53e3\u88d5\u7ae0\u30fb\u91ce\u6751\u592a\u4e00\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). Bassoon\u907a\u4f1d\u5b50\u30d0\u30ea\u30a2\u30f3\u30c8\u3068\u795e\u7d4c\u75be\u60a3\u306e\u95a2\u4fc2\u6027. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u3000\u30db\u30c3\u30c8\u30c8\u30d4\u30c3\u30af\u30b908. <\/p>\n\n\n\n
\u77e2\u90e8\u4e00\u90ce. (2025). \u30c0\u30cb\u5a92\u4ecb\u8133\u708e. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u3000\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc48. <\/p>\n\n\n\n
\u5c71\u7530\u4e00\u8cb4\u30fb\u4e2d\u6751\u4fca\u592a\u90ce\u30fb\u7530\ufa11\u5065\u592a\u30fb\u539f\u8aa0\u30fb\u5800\u5185\u4e00\u5b8f\u30fb\u77e2\u90e8\u4e00\u90ce. (2025). \u6cbb\u7642\u958b\u59cb\u307e\u3067\u306e\u6642\u9593\u5dee\u306b\u3088\u308a\u4e88\u5f8c\u304c\u5927\u304d\u304f\u7570\u306a\u3063\u305f\u6297Caspr2\u8133\u708e\u306e2\u4f8b. \u7b2c37\u56de\u65e5\u672c\u795e\u7d4c\u514d\u75ab\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. <\/p>\n\n\n\n
\u5c71\u7530\u664b\u4e00\u90ce\u30fb\u6e05\u6c34\u3000\u5fcd\u30fb\u5929\u91ce\u7950\u7406\u30fb\u82e5\u6749\u5b9c\u7f8e\u30fb\u6728\u4e0b\u6587\u6075\u30fb\u5cb8\u672c\u7965\u4e4b\u30fb\u5ddd\u702c\u5d07\u5e83\u30fb\u6a4b\u8a70\u3000\u6df3\u30fb\u4f0a\u85e4\u5927\u8f14\u30fb\u8fd1\u85e4\u5f69\u4e43\u30fb\u68ee\u3000\u60a0\u30fb\u5c71\u672c\u5b97\u9686\u30fb\u77e2\u90e8\u4e00\u90ce\u30fb\u68ee\u7530\u5149\u54c9\u30fb\u6851\u539f\u3000\u8061\u30fb\u6238\u7530\u9054\u53f2\u30fb\u9577\u91ce\u6e05\u4e00\u30fb\u52dd\u91ce\u96c5\u592e. (2025). \u7403\u810a\u9ac4\u6027\u7b4b\u840e\u7e2e\u75c7\u306b\u5bfe\u3057\u3066\u30e1\u30ad\u30b7\u30ec\u30c1\u30f3\u5869\u9178\u5869\u3092\u6295\u4e0e\u3059\u308b\u533b\u5e2b\u4e3b\u5c0e\u6cbb\u9a13\u306e\u30d7\u30ed\u30c8\u30b3\u30fc\u30eb. \u7b2c66\u56de\u65e5\u672c\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a. <\/p>\n\n\n\n
\u5c71\u5143\u4f51\u4e5f\u30fb\u9ad8\u6a4b\u4f38\u5e78. (2025). \u793e\u4f1a\u7684\u4ea4\u63db\u306b\u304a\u3051\u308b\u516c\u6b63\u6027\u8a8d\u77e5\u518d\u8003\uff0d\u898f\u5b9a\u56e0\u3068\u8a55\u4fa1\u5bfe\u8c61\u306e\u591a\u69d8\u6027\u306b\u7740\u76ee\u3057\u305f\u691c\u8a0e\uff0d\u3010\u7814\u7a76\u8a08\u753b\u3011. \u65e5\u672c\u4eba\u9593\u884c\u52d5\u9032\u5316\u5b66\u4f1a\u7b2c18\u56de\u5927\u4f1a. <\/p>\n\n\n\n
\u5c71\u5143\u4f51\u4e5f\u30fb\u9ad8\u6a4b\u4f38\u5e78. (2025). \u9593\u63a5\u4e92\u6075\u6027\u72b6\u6cc1\u306b\u304a\u3044\u3066\u4ed6\u8005\u306e\u8a55\u4fa1\u30eb\u30fc\u30eb\u304c\u660e\u793a\u7684\u3067\u3042\u308b\u3068\u304d\u306b\u4eba\u3005\u306f\u884c\u52d5\u3092\u8abf\u6574\u3059\u308b\u306e\u304b. \u65e5\u672c\u30b0\u30eb\u30fc\u30d7\u30fb\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u30b9\u5b66\u4f1a\u7b2c71\u56de\u5927\u4f1a. <\/p>\n\n\n\n
\u7d50\u57ce\u96c5\u6a39\u30fb\u65e5\u4e0b\u90e8\u6625\u91ce. (2025). \u6587\u5316\u5fc3\u7406\u5b66\u306e\u56db\u3064\u306e\u300c\u306a\u305c\u300d:\u30c6\u30a3\u30f3\u30d0\u30fc\u30b2\u30f3\u306e\u67a0\u7d44\u307f\u306b\u3088\u308b\u518d\u6574\u7406. \u65e5\u672c\u4eba\u9593\u884c\u52d5\u9032\u5316\u5b66\u4f1a\u7b2c18\u56de\u5927\u4f1a.<\/p>\n\n\n\n
<\/p>\n","protected":false},"excerpt":{"rendered":"\u5b89\u9054\u5bdb\u5b50\u30fb\u67ff\u4e26\u7fa9\u5b8f\u30fb\u90e1\u5c71\u5c1a\u7d00\u30fb\u8d8a\u91ce \u4e00\u535a\u30fb\u7027\u672c(\u732a\u702c)\u5f69\u52a0. (2025). \u5b50\u3092\u5168\u982d\u3067\u5b88\u308b\uff1a\u98fc\u80b2\u4e0b\u30a2\u30b8\u30a2\u30be\u30a6\u306e\u975e\u8840\u7e01\u7fa4\u308c\u306b\u304a\u3051\u308b\u8b66\u6212\u30fb\u96c6\u5408\u8981\u56e0\u306e\u63a2\u7d22\u7684\u691c\u8a0e. \u65e5\u672c\u52d5\u7269\u884c\u52d5\u5b66\u4f1a\u7b2c44\u56de\u5927\u4f1a. \u8d64\u6c60\u3000\u77ac...","protected":false},"author":2,"featured_media":1493,"parent":85,"menu_order":2023,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2407","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/lynx.let.hokudai.ac.jp\/cerss\/wp-json\/wp\/v2\/pages\/2407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lynx.let.hokudai.ac.jp\/cerss\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lynx.let.hokudai.ac.jp\/cerss\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lynx.let.hokudai.ac.jp\/cerss\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/lynx.let.hokudai.ac.jp\/cerss\/wp-json\/wp\/v2\/comments?post=2407"}],"version-history":[{"count":1,"href":"https:\/\/lynx.let.hokudai.ac.jp\/cerss\/wp-json\/wp\/v2\/pages\/2407\/revisions"}],"predecessor-version":[{"id":2408,"href":"https:\/\/lynx.let.hokudai.ac.jp\/cerss\/wp-json\/wp\/v2\/pages\/2407\/revisions\/2408"}],"up":[{"embeddable":true,"href":"https:\/\/lynx.let.hokudai.ac.jp\/cerss\/wp-json\/wp\/v2\/pages\/85"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lynx.let.hokudai.ac.jp\/cerss\/wp-json\/wp\/v2\/media\/1493"}],"wp:attachment":[{"href":"https:\/\/lynx.let.hokudai.ac.jp\/cerss\/wp-json\/wp\/v2\/media?parent=2407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}